UHT — Universal Health Realty Income Trust stock price, charts and financials
QT43Universal Health Realty Income TrustUniversal Health Realty Income Trust (NYSE: UHT) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
41.38
-1.34-3.14%
TA
Loading chart...
Snapshot
| Index | - | P/E | 30.51 | EPS (ttm) | 1.40 | Insider Own | 3.18% | Shs Outstand | 13.88M | Perf Week | -1.61% |
| Market Cap | 592.77M | Forward P/E | 23.47 | EPS next Y | 1.82 | Insider Trans | 0.00% | Shs Float | 12.77M | Perf Month | -2.04% |
| Enterprise Value | 981.05M | PEG | 4.44 | EPS next Q | - | Inst Own | - | Short Float | 2.95% | Perf Quarter | 4.96% |
| Income | 19.32M | P/S | 3.98 | EPS this Y | 23.57% | Inst Trans | - | Short Ratio | 2.50 | Perf Half Y | 0.05% |
| Sales | 148.79M | P/B | 4.11 | EPS next Y | 5.20% | ROA | 3.40% | Short Interest | 376.77K | Perf YTD | 8.95% |
| Book/sh | - | P/C | 16.54 | EPS next 5Y | 5.13% | ROE | 12.79% | 52W High | 44.85 -7.73% | Perf Year | 12.39% |
| Cash/sh | - | P/FCF | 16.58 | EPS past 3/5Y | -6.02% -2.07% | ROIC | 151.76% | 52W Low | 34.15 21.16% | Perf 3Y | -10.31% |
| Dividend Est. | 3.00 (7.25%) | EV/EBITDA | 15.04 | Sales past 3/5Y | 2.85% 4.88% | Gross Margin | 76.10% | Volatility | 2.96% 2.53% | Perf 5Y | -28.50% |
| Dividend TTM | 2.98 (7.20%) | EV/Sales | 6.59 | EPS Y/Y TTM | 0.72% | Oper. Margin | 36.46% | ATR (14) | 1.18 | Perf 10Y | -27.49% |
| Dividend Ex-Date | Jun 22, 2026 | Quick Ratio | 0.00 | Sales Y/Y TTM | 50.51% | Profit Margin | 12.95% | RSI (14) | 47.80 | Recom | 3.00 |
| Dividend Gr. 3/5Y | 1.39% 1.41% | Current Ratio | 0.00 | EPS Q/Q | -49.41% | SMA20 | -1.48% | Beta | 0.84 | Target Price | - |
| Payout | 160.13% | Debt/Eq | 2.75 | Sales Q/Q | 0.00% | SMA50 | 1.16% | Rel Volume | 0.60 | Prev Close | 42.72 |
| Employees | - | LT Debt/Eq | 2.53 | Earnings | Oct 26 | SMA200 | 3.78% | Avg Volume | 160.15K | Price | 41.38 |
| IPO Date | Dec 26, 1986 | Option/Short | Yes / Yes | EPS/Sales Surpr. | - 1.18% | Net Debt/EBITDA | 5.95 | Volume | 95,706 | Change | -3.14% |
Latest News
Aug-05-26
Jul-30-26
Jul-27-26
Jul-27-2604:20PM
04:16PM
07:45AM
Jul-09-26
Jul-09-2602:42PM
Jun-26-26
Jun-26-2605:55PM
Jun-18-26
Jun-14-26
Jun-12-26
Jun-12-2606:45PM
Company
Universal Health Realty Income Trust (UHT) operates as a real estate investment trust (REIT) dedicated to investing in properties within the healthcare and human services industries. Its portfolio is diverse, encompassing a range of facilities such as acute care hospitals, rehabilitation centers, sub-acute care facilities, medical office buildings, freestanding emergency departments, and childcare centers. The trust currently holds 71 properties across 20 U.S. states, two of which are actively under construction.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 149 | 99 | 99 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 35 | 6 | 5 | — | — | — | — | — | — | |
| Gross Profit | 113 | 94 | 94 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 2 | 0 | 0 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 56 | 59 | 57 | — | — | — | — | — | — | |
| Operating Income | 54 | 35 | 37 | — | — | — | — | — | — | |
| Interest Expense | 28 | 22 | 24 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -8 | 5 | 6 | — | — | — | — | — | — | |
| Net Income Before Taxes | 19 | 18 | 19 | — | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | 19 | 18 | 19 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 19 | 18 | 19 | — | — | — | — | — | — | |
| Net Income | 19 | 18 | 19 | — | — | — | — | — | — | |
| EPS (Recurring) | 1.40 | 1.27 | 1.39 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.40 | 1.27 | 1.39 | — | — | — | — | — | — | |
| EPS (Diluted) | 1.40 | 1.27 | 1.39 | — | — | — | — | — | — | |
| EBITDA | 64 | 68 | 70 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 29.56 | 30.87 | 26.77 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.89 | 5.54 | 5.26 | — | — | — | — | — | — | |
| Gross Margin | 75.84 | 94.95 | 94.95 | — | — | — | — | — | — | |
| Operating Margin | 36.24 | 35.35 | 37.37 | — | — | — | — | — | — | |
| Net Margin | 12.75 | 18.18 | 19.19 | — | — | — | — | — | — | |
| Shares Outstanding | 14 | 14 | 14 | — | — | — | — | — | — | |
| Market Capitalization | 579 | 549 | 521 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MILLER ALAN B | President, and CEO | Oct 29 '25 | Buy | 37.02 | 12,247 | 453,405 | 182,104 | Oct 30 |
| McCadden Robert F | Director | May 09 '24 | Buy | 37.38 | 2,000 | 74,760 | 11,644 | May 09 |
| MILLER ALAN B | President, and CEO | Apr 26 '24 | Buy | 34.65 | 6,000 | 207,881 | 157,753 | Apr 26 |
| MILLER ALAN B | President, and CEO | May 03 '23 | Buy | 43.18 | 2,395 | 103,414 | 147,141 | May 03 |
| McCadden Robert F | Director | Mar 10 '23 | Buy | 48.12 | 1,000 | 48,123 | 9,046 | Mar 10 |
| MILLER ALAN B | President, and CEO | Mar 07 '23 | Buy | 48.81 | 2,000 | 97,618 | 144,746 | Mar 08 |
| MILLER ALAN B | President, and CEO | Sep 14 '22 | Buy | 48.32 | 2,000 | 96,634 | 142,746 | Sep 15 |
| MILLER ALAN B | President, and CEO | Sep 08 '22 | Buy | 48.90 | 2,000 | 97,801 | 140,746 | Sep 09 |
| McCadden Robert F | Director | May 11 '22 | Buy | 47.81 | 500 | 23,903 | 7,500 | May 12 |
| McCadden Robert F | director: | May 10 '22 | Buy | 47.88 | 2,000 | 95,760 | 7,000 | May 12 |
| Domb Michael Allan | Director | Sep 10 '21 | Buy | 56.25 | 2,800 | 157,500 | 9,600 | Sep 10 |
| Domb Michael Allan | Director | Sep 09 '21 | Buy | 56.15 | 3,000 | 168,450 | 6,800 | Sep 10 |
| MILLER ALAN B | President, and CEO | Aug 17 '21 | Buy | 57.16 | 4,500 | 257,206 | 134,655 | Aug 18 |
| Domb Michael Allan | Director | Sep 10 '20 | Buy | 66.00 | 2,200 | 145,200 | 3,400 | Sep 10 |
| MILLER ALAN B | President, and CEO | Jul 30 '20 | Buy | 68.31 | 1,500 | 102,468 | 127,105 | Jul 31 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.